Nick R Anthonisen. Show Affiliations »
Abstract
Mesh: See more » Albuterol/analogs & derivativesAlbuterol/economicsAlbuterol/therapeutic useAndrostadienes/economicsAndrostadienes/therapeutic useAsthma/diagnosisAsthma/drug therapyAsthma/economicsBronchodilator Agents/administration & dosageBronchodilator Agents/economicsBronchodilator Agents/therapeutic useBudesonide/economicsBudesonide/therapeutic useCanadaCost-Benefit AnalysisDrug CostsDrug Therapy, CombinationEthanolamines/economicsEthanolamines/therapeutic useEvaluation Studies as TopicFluticasoneFormoterol FumarateHospitalization/economicsHumansPeak Expiratory Flow RateSalmeterol XinafoateSputum/cytology
Substances: See more » AndrostadienesBronchodilator AgentsEthanolaminesBudesonideSalmeterol XinafoateFluticasoneAlbuterolFormoterol Fumarate
Year: 2007 PMID: 17874484 PMCID: PMC2676388 DOI: 10.1155/2007/107253
Source DB: PubMed Journal: Can Respir J ISSN: 1198-2241 Impact factor: 2.409